Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Valent

Showing results (391-400 of 662) with videos related to

Pageof 67
Sort By:
Nature Communications|September 19, 2023
ABCC1 and glutathione metabolism limit the efficacy of BCL-2 inhibitors in acute myeloid leukemiaJessica Ebner, Johannes Schmoellerl, Martin Piontek, et al.
Haematologica|January 19, 2011
Polo-like kinase-1 as a novel target in neoplastic mast cells: demonstration of growth-inhibitory effects of small interfering RNA and the Polo-like kinase-1 targeting drug BI 2536Barbara Peter, Karoline V Gleixner, Sabine Cerny-Reiterer, et al.
Oncotarget|October 6, 2017
The pan-BCL-2-blocker obatoclax (GX15-070) and the PI3-kinase/mTOR-inhibitor BEZ235 produce cooperative growth-inhibitory effects in ALL cellsGabriele Stefanzl, Daniela Berger, Sabine Cerny-Reiterer, et al.
Haematologica|March 4, 2017
The clinical and molecular diversity of mast cell leukemia with or without associated hematologic neoplasmMohamad Jawhar, Juliana Schwaab, Manja Meggendorfer, et al.
Leukemia|March 15, 2023
Engraftment in NSG<sub>SCF</sub> mice correlates with the WHO category and prognosis in systemic mastocytosisMichael Willmann, Barbara Peter, Katharina Slavnitsch, et al.
Leukemia & Lymphoma|September 20, 2012
Anti-Fas/CD95 and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) differentially regulate apoptosis in normal and neoplastic human basophilsAnja Förster, Franco H Falcone, Bernhard F Gibbs, et al.
American Journal of Cancer Research|May 15, 2015
Prominin-1 (CD133, AC133) and dipeptidyl-peptidase IV (CD26) are indicators of infinitive growth in colon cancer cellsThomas W Grunt, Alexandra Hebar, Sylvia Laffer, et al.
Blood|August 7, 2010
The classification of systemic mastocytosis should include mast cell leukemia (MCL) and systemic mastocytosis with a clonal hematologic non-mast cell lineage disease (SM-AHNMD)Peter Valent, Michel Arock, Cem Akin, et al.
Biological Chemistry|November 20, 2002
Purification, structural and immunological characterization of a timothy grass (Phleum pratense) pollen allergen, Phl p 4, with cross-reactive potentialSabine Stumvoll, Jonas Lidholm, Roland Thunberg, et al.
Blood|April 11, 2007
Identification of heat shock protein 32 (Hsp32) as a novel survival factor and therapeutic target in neoplastic mast cellsRudin Kondo, Karoline V Gleixner, Matthias Mayerhofer, et al.
Pageof 67

Showing results (391-400 of 662) with videos related to

Sort By:
Pageof 67
Nature Communications|September 19, 2023
ABCC1 and glutathione metabolism limit the efficacy of BCL-2 inhibitors in acute myeloid leukemiaJessica Ebner, Johannes Schmoellerl, Martin Piontek, et al.
Haematologica|January 19, 2011
Polo-like kinase-1 as a novel target in neoplastic mast cells: demonstration of growth-inhibitory effects of small interfering RNA and the Polo-like kinase-1 targeting drug BI 2536Barbara Peter, Karoline V Gleixner, Sabine Cerny-Reiterer, et al.
Oncotarget|October 6, 2017
The pan-BCL-2-blocker obatoclax (GX15-070) and the PI3-kinase/mTOR-inhibitor BEZ235 produce cooperative growth-inhibitory effects in ALL cellsGabriele Stefanzl, Daniela Berger, Sabine Cerny-Reiterer, et al.
Haematologica|March 4, 2017
The clinical and molecular diversity of mast cell leukemia with or without associated hematologic neoplasmMohamad Jawhar, Juliana Schwaab, Manja Meggendorfer, et al.
Leukemia|March 15, 2023
Engraftment in NSG<sub>SCF</sub> mice correlates with the WHO category and prognosis in systemic mastocytosisMichael Willmann, Barbara Peter, Katharina Slavnitsch, et al.
Leukemia & Lymphoma|September 20, 2012
Anti-Fas/CD95 and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) differentially regulate apoptosis in normal and neoplastic human basophilsAnja Förster, Franco H Falcone, Bernhard F Gibbs, et al.
American Journal of Cancer Research|May 15, 2015
Prominin-1 (CD133, AC133) and dipeptidyl-peptidase IV (CD26) are indicators of infinitive growth in colon cancer cellsThomas W Grunt, Alexandra Hebar, Sylvia Laffer, et al.
Blood|August 7, 2010
The classification of systemic mastocytosis should include mast cell leukemia (MCL) and systemic mastocytosis with a clonal hematologic non-mast cell lineage disease (SM-AHNMD)Peter Valent, Michel Arock, Cem Akin, et al.
Biological Chemistry|November 20, 2002
Purification, structural and immunological characterization of a timothy grass (Phleum pratense) pollen allergen, Phl p 4, with cross-reactive potentialSabine Stumvoll, Jonas Lidholm, Roland Thunberg, et al.
Blood|April 11, 2007
Identification of heat shock protein 32 (Hsp32) as a novel survival factor and therapeutic target in neoplastic mast cellsRudin Kondo, Karoline V Gleixner, Matthias Mayerhofer, et al.
Pageof 67